SPARC (secreted protein acidic & rich in cysteine) belongs to the matricellular class of secreted glycoproteins. Although structurally dissimilar, these proteins regulate interactions between cells & their extracellular matrix (ECM) & feature prominently in morphogenesis, development, injury, & repair. SPARC has been shown to i) inhibit the cell cycle; ii) disrupt cell adhesion; iii) inactivate cellular responses to certain growth factors; iv) regulate ECM & matrix metalloproteinase (MMP) production; v) bind to specific collagens; & vi) promote a rounded cell shape through dissolution of focal adhesions & reorganization of the actin cytoskeleton. SPARC- null mice are viable but exhibit phenotypic abnormalities associated with the eye, connective & adipose tissues, bone, & wound healing. Moreover, cells cultured from SPARC-null vs. wild-type tissues showed significantly accelerated cell cycles, diminished production of collagen & transforming growth factor b- 1, enhanced adhesion, &/or altered levels of cadherins & matricellular proteins. The expression of SPARC in remodeling tissues, as a consequence of normal development or response to injury, coupled with its multiple effects on vascular cells of the vessel wall, has been consistent with our proposal that SPARC subserves a fundamental role in vascular morphogenesis & cellular differentiation. In this renewal application on the role of SPARC in blood vessel growth, we test 4 hypotheses based on our current knowledge of SPARC structure & function: 1) Certain characteristics of SPARC-null mice are related to compromised angio- or vasculogenesis; 2) Mice lacking both SPARC & its homolog SC1 will exhibit exacerbated vascular & connective/adipose tissue phenotypes, due in part to the release of conserved, bioactive peptides by MMP-3; 3) A target for the counteradhesive activity of SPARC in endothelial cells is VE-cadherin & components of its signaling pathway; 4) SPARC is a significant regulator of several activities of vascular endothelial growth factor on endothelial cells. The proposed experiments will provide a more precise understanding of how vessels grow in the context of signals mediated by SPARC, a dynamic resident of the extracellular space.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM040711-15
Application #
6370545
Study Section
Pathology A Study Section (PTHA)
Program Officer
Ikeda, Richard A
Project Start
1989-07-01
Project End
2005-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
15
Fiscal Year
2001
Total Cost
$318,500
Indirect Cost
Name
The Hope Heart Institute
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98122
Cheng, Lamei; Sage, E Helene; Yan, Qi (2013) SPARC fusion protein induces cellular adhesive signaling. PLoS One 8:e53202
Millecamps, Magali; Tajerian, Maral; Naso, Lina et al. (2012) Lumbar intervertebral disc degeneration associated with axial and radiating low back pain in ageing SPARC-null mice. Pain 153:1167-79
Kucukdereli, Hakan; Allen, Nicola J; Lee, Anthony T et al. (2011) Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc Natl Acad Sci U S A 108:E440-9
Nie, Jing; Bradshaw, Amy D; Delany, Anne M et al. (2011) Inactivation of SPARC enhances high-fat diet-induced obesity in mice. Connect Tissue Res 52:99-108
Workman, Gail; Sage, E Helene (2011) Identification of a sequence in the matricellular protein SPARC that interacts with the scavenger receptor stabilin-1. J Cell Biochem 112:1003-8
Millecamps, Magali; Tajerian, Maral; Sage, E Helene et al. (2011) Behavioral signs of chronic back pain in the SPARC-null mouse. Spine (Phila Pa 1976) 36:95-102
Weaver, Matt; Workman, Gail; Schultz, Chad R et al. (2011) Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model. J Cell Biochem 112:3093-102
Weaver, Matt S; Workman, Gail; Cardo-Vila, Marina et al. (2010) Processing of the matricellular protein hevin in mouse brain is dependent on ADAMTS4. J Biol Chem 285:5868-77
Arnold, Shanna A; Rivera, Lee B; Miller, Andrew F et al. (2010) Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma. Dis Model Mech 3:57-72
Nie, Jing; Sage, E Helene (2009) SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. J Biol Chem 284:1279-90

Showing the most recent 10 out of 127 publications